Subscribe to the MEDICI Inner Circle Membership and gain access to an exclusive WhatsApp community where you can engage in discussions with global industry experts!
OpenGamma is the analytics company dedicated to reducing the costs of trading derivatives, by providing actionable recommendations to front-office, risk and treasury. Our deep quantitative understanding of CCP margin and capital models, coupled with our cutting edge cloud-based technologies, give derivatives users the ability to uncover hidden opportunities that enhance returns. Since our founding in 2009, OpenGamma has built a global client base consisting of the worlds leading financial institutions and companies across clearing houses, banks and buy-side firms. Due to our simple set-up, clients are up and running within hours, receiving actionable recommendations for immediate derivatives cost savings.With offices in London and New York, our team brings together a unique mix of practitioner, quantitative and software engineering expertise, providing unique insights, and products designed from direct experience. With thousands of users depending on our derivatives analytics everyday, OpenGamma helps firms tackle the biggest issues in derivatives trading.For more information visit www.opengamma.com
Opengamma is a developer of market risk management platform for financial services firms which is designed to optimize their businesses in the evolving OTC markets.
OpenGamma helps financial services industry by providing an open-source platform called Strata which enables derivatives risk management and analytics solutions specifically for the use in the derivatives OTC markets. The company refers to its solutions as "Risk as a Service" that encompasses ETD & OTC margin calculations, bilateral OTC margining, and derivatives MTM & Greeks calculation. It allows users to use Strata and create customize solutions for their analytics platform.
Opengamma earns revenue by collecting annual fee from customers.
Financial Services companies
The company is planning to offer a cost-effective and nimble alternative to legacy, enterprise-wide platforms by using an innovative range of software-as-a-service (SaaS) solutions based on an open source library of standardized derivatives pricing and risk models.
$187.5 M in 2015
Sign up for 7 days free trial with MEDICI Inner Circle to follow and track profiles you care about.